Preeclampsia Genomic Susceptibility Factors in Populations of African Ancestry: A Systematic Review and Meta-Analysis

The aim of this review is to examine the contribution of genomic variation to preeclampsia susceptibility in Africans. PubMed/Medline, Scopus, African Index Medicus and Sabinet African Journals databases were used to access studies conducted in populations of African descent focussing on the genomics of preeclampsia. Studies were selected according to PRISMA guidelines and assessed for quality and risk of bias using the Critical Appraisal Skills Programme (CASP) and Joanna Briggs Institute (JBI) checklists. Meta-analysis was conducted using a random effects model, and publication bias was evaluated using the Eggers test and funnel plots. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) was applied to evaluate the certainty of evidence outcomes. Sixty-six (66) studies reporting on genomics of preeclampsia were retrieved. Forty-four (44) studies had a quality assessment score ≥75%. Vascular pathway genes (<i>GNB3</i>, <i>FLT1</i>, <i>NOS3</i> and <i>VEGFC</i>; OR (95% CI): 1.61 (1.38-1.88); <i>I</i><sup>2</sup>: 0.0%, <i>p</i> = 0.87; GRADE: low certainty), immune/inflammatory pathway genes (<i>APOL1</i>, <i>ERAP2</i>, <i>HLA-G</i>, <i>IL-1β</i>, <i>LEPR</i> and <i>TNF-α</i>; OR (95% CI): 2.07 (1.68-2.54); <i>I</i><sup>2</sup>: 42.2%, <i>p</i> = 0.04; GRADE: low certainty) and cellular homeostasis genes (<i>GLUT9</i>, <i>URAT1</i>, <i>SLC4A1</i> and <i>SLCO4C1</i>; OR (95% CI): 1.65 (1.43-1.91); <i>I</i><sup>2</sup>: 0.0%, <i>p</i> = 0.99; GRADE: low certainty) showed pooled effect estimates suggestive of moderate to increased preeclampsia risk. <i>APOL1</i> G1 or G2 risk alleles seemed to contribute 1.70-fold (95% CI: 1.39-2.07; <i>I</i><sup>2</sup>: 0.0%; <i>p</i> = 0.51; GRADE: low certainty), respectively, to overall preeclampsia risk. Vascular, immune/inflammatory and cellular homeostasis genes may be ideal starting points for future research, and further validation of the role of <i>APOL1</i> G1 or G2 risk alleles in preeclampsia may be essential.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-03-12
DOI
https://doi.org/10.3390/ijms27062594
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Preeclampsia Genomic Susceptibility Factors in Populations of African Ancestry: A Systematic Review and Meta-Analysis

Mushi J. Matjila, Bianca Davidson, Khuthala Mnika, Collet Dandara et al.
International Journal of Molecular Sciences
Pregnancy and preeclampsia studies
article

Preeclampsia Genomic Susceptibility Factors in Populations of African Ancestry: A Systematic Review and Meta-Analysis

Mushi J. Matjila, Bianca Davidson, Khuthala Mnika, Collet Dandara, Erika Jones, Nyarai D. Soko, Jonathan N. Katsukunya, Ayesha Osman
article en

Abstract

The aim of this review is to examine the contribution of genomic variation to preeclampsia susceptibility in Africans. PubMed/Medline, Scopus, African Index Medicus and Sabinet African Journals databases were used to access studies conducted in populations of African descent focussing on the genomics of preeclampsia. Studies were selected according to PRISMA guidelines and assessed for quality and risk of bias using the Critical Appraisal Skills Programme (CASP) and Joanna Briggs Institute (JBI) checklists. Meta-analysis was conducted using a random effects model, and publication bias was evaluated using the Eggers test and funnel plots. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) was applied to evaluate the certainty of evidence outcomes. Sixty-six (66) studies reporting on genomics of preeclampsia were retrieved. Forty-four (44) studies had a quality assessment score ≥75%. Vascular pathway genes (<i>GNB3</i>, <i>FLT1</i>, <i>NOS3</i> and <i>VEGFC</i>; OR (95% CI): 1.61 (1.38-1.88); <i>I</i><sup>2</sup>: 0.0%, <i>p</i> = 0.87; GRADE: low certainty), immune/inflammatory pathway genes (<i>APOL1</i>, <i>ERAP2</i>, <i>HLA-G</i>, <i>IL-1β</i>, <i>LEPR</i> and <i>TNF-α</i>; OR (95% CI): 2.07 (1.68-2.54); <i>I</i><sup>2</sup>: 42.2%, <i>p</i> = 0.04; GRADE: low certainty) and cellular homeostasis genes (<i>GLUT9</i>, <i>URAT1</i>, <i>SLC4A1</i> and <i>SLCO4C1</i>; OR (95% CI): 1.65 (1.43-1.91); <i>I</i><sup>2</sup>: 0.0%, <i>p</i> = 0.99; GRADE: low certainty) showed pooled effect estimates suggestive of moderate to increased preeclampsia risk. <i>APOL1</i> G1 or G2 risk alleles seemed to contribute 1.70-fold (95% CI: 1.39-2.07; <i>I</i><sup>2</sup>: 0.0%; <i>p</i> = 0.51; GRADE: low certainty), respectively, to overall preeclampsia risk. Vascular, immune/inflammatory and cellular homeostasis genes may be ideal starting points for future research, and further validation of the role of <i>APOL1</i> G1 or G2 risk alleles in preeclampsia may be essential.

International Journal of Molecular SciencesVol. 27(6)
South African Medical Research Council (ZA), University of Cape Town (ZA), Harare Institute of Technology (ZW), Groote Schuur Hospital (ZA), Wellcome Centre for Infectious Diseases Research in Africa (ZA)
Department of Science and Innovation, South Africa, National Research Foundation, South African Medical Research Council, Medical Research Council
Quality Education
Openalex Percentile: Top 24%
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.